Lobbying disclosures · Lobbying report
RVTY: third_quarter 2026 lobbying report
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810 - Family Cord Blood Banking Act
Follow RVTY- Became public
- Oct 15, 2026, 11:16 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 9, 2026, 4:27 AM EST
Why this is connected
Exact legal-name match: REVVITY, INC. (https://www.sec.gov/Archives/edgar/data/31791/).
Reported lobbying amounts
Expenses: $40,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/678a6fd7-980a-4ec1-bb26-8fcc3094e5b3/","filing_uuid":"678a6fd7-980a-4ec1-bb26-8fcc3094e5b3","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/678a6fd7-980a-4ec1-bb26-8fcc3094e5b3/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Luis M. Tovar","dt_posted":"2026-10-15T11:16:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"77 4th Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02451","registrant":{"id":401105953,"url":"https://lda.gov/api/v1/registrants/401105953/","house_registrant_id":null,"name":"REVVITY, INC.","description":"Provides products and services for Life Sciences/Diagnostics.","address_1":"77 4th Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02451","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUIS M. TOVAR","contact_telephone":"+1 774-422-9041","dt_updated":"2026-07-10T13:42:56.425475-04:00"},"client":{"id":208897,"url":"https://lda.gov/api/v1/clients/208897/","client_id":12,"name":"REVVITY, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-03-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810 - Family Cord Blood Banking Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149946,"prefix":null,"prefix_display":null,"first_name":"LUIS","nickname":null,"middle_name":"M.","last_name":"TOVAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Price change after we could observe it
-0.53% RVTY
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in RVTY
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 13, 2026 · disclosed Nov 5, 2026 · Dependent
- Oct 12, 2026$15K–$50K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$15K–$50K · Traded Sep 9, 2026 · disclosed Oct 12, 2026
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 12, 2026
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Sep 3, 2026 · disclosed Oct 12, 2026
- Jun 8, 2026$15K–$50K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$15K–$50K · Traded May 4, 2026 · disclosed Jun 8, 2026
- May 8, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded May 1, 2026 · disclosed May 8, 2026
- Oct 10, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Sep 12, 2025 · disclosed Oct 10, 2025
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Aug 26, 2025 · disclosed Sep 12, 2025 · Dependent
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.